Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update.

Literature DB >> 28214949

Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update.

Manuel Cappellari¹, Stefano Forlivesi², Giovanna Maddalena Squintani², Roberto Facchinetti³, Paolo Bovi².

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2017 PMID： 28214949 DOI： 10.1007/s11239-017-1485-1

Source DB: PubMed Journal: J Thromb Thrombolysis ISSN： 0929-5305 Impact factor: 2.300

× No keyword cloud information.

5 in total

Review 1. Idarucizumab: The Antidote for Reversal of Dabigatran.

Authors: John W Eikelboom; Daniel J Quinlan; Joanne van Ryn; Jeffrey I Weitz
Journal: Circulation Date: 2015-12-22 Impact factor: 29.690

Review 2. Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update.

Authors: M Cappellari; P Bovi
Journal: Thromb Haemost Date: 2015-03-26 Impact factor: 5.249

3. Idarucizumab for Dabigatran Reversal.

Authors: Charles V Pollack; Paul A Reilly; John Eikelboom; Stephan Glund; Peter Verhamme; Richard A Bernstein; Robert Dubiel; Menno V Huisman; Elaine M Hylek; Pieter W Kamphuisen; Jörg Kreuzer; Jerrold H Levy; Frank W Sellke; Joachim Stangier; Thorsten Steiner; Bushi Wang; Chak-Wah Kam; Jeffrey I Weitz
Journal: N Engl J Med Date: 2015-06-22 Impact factor: 91.245

4. Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants.

Authors: Jan C Purrucker; Marcel Wolf; Kirsten Haas; Timolaos Rizos; Shujah Khan; Rainer Dziewas; Christoph Kleinschnitz; Andreas Binder; Klaus Gröschel; Michael G Hennerici; Kyriakos Lobotesis; Sven Poli; Günter Seidel; Tobias Neumann-Haefelin; Peter A Ringleb; Peter U Heuschmann; Roland Veltkamp
Journal: Stroke Date: 2016-03-01 Impact factor: 7.914

5. Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.

Authors: Hein Heidbuchel; Peter Verhamme; Marco Alings; Matthias Antz; Hans-Christoph Diener; Werner Hacke; Jonas Oldgren; Peter Sinnaeve; A John Camm; Paulus Kirchhof
Journal: Eur Heart J Date: 2017-07-14 Impact factor: 29.983

5 in total

6 in total

1. Evidence for Idarucizumab (Praxbind) in the Reversal Of the Direct Thrombin Inhibitor Dabigatran: Review Following the RE-VERSE AD Full Cohort Analysis.

Authors: Timothy C Hutcherson; Nicole E Cieri-Hutcherson; Rajvi Bhatt
Journal: P T Date: 2017-11

2. Thrombolysis in Acute Ischemic Stroke after Idarucizumab for Dabigatran Etexilate Reversal in Elderly: A Case Report.

Authors: Antonio Baule; Federico Cabigiosu; Bastianina Zanda; Alessandra Sanna; Claudia Mongili; Antonio Manca
Journal: J Vasc Interv Neurol Date: 2018-11

Review 3. Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence.

Authors: Slaven Pikija; Laszlo K Sztriha; J Sebastian Mutzenbach; Stefan M Golaszewski; Johann Sellner
Journal: CNS Drugs Date: 2017-09 Impact factor: 5.749